glp-1 obesity drug news today 2025-10-20 Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and The Obesity Society Market Overview: GLP-1 Agonists and

Because some oral options are compounded, dosing and absorption can vary by product and pharmacy

Chandel NS

Notably, the effect of tirzepatide as an anti-obesity medication is being investigated in the ongoing SURMOUNT clinical trial programme, in a similar manner to the assessment of semaglutide 2.4 mg for obesity in the Semaglutide Treatment Effect in People with obesity (STEP) programme [27]

The diabetes-induced reduction of neurogenesis in the hippocampal dentate implies a potential mechanism for diabetes-related cognitive decline

3 Start losing weight Get your treatment plan, prescriptions (if appropriate), and ongoing support from your provider and dietitian, all covered by your insurance